National Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation

National Scleroderma Foundation Logo 2022 eletter

 

eLetter #988 | August 23, 2022  

KGS2 Logo

Kids Get Scleroderma, Too! Virtual Conference

VIRTUAL: October 22, 2022

Sign up now for the 2022 Kids Get Scleroderma, Too! Conference (KGS2). This virtual education conference is geared toward parents, guardians, and juveniles affected by scleroderma. Stay tuned for more information on conference programming!

SIGN UP


20% Men's Support Group

The 20%: A Virtual Support Group for Males Living with Scleroderma

ZOOM: September 28, 2022; 7 p.m. Eastern

Scleroderma diagnoses are less common amongst males. In fact, only 20% of individuals living with scleroderma are male. We have designed a support group, especially for males with scleroderma. In it, you will learn scleroderma tips and resources and find support from others in your position. Each meeting, we will focus on a different topic from mental health to intimacy and so much more. The group meets on the fourth Wednesday of the month (with some exceptions) from 7 to 8 p.m. Eastern.

SIGN UP


CFC #10089 Image

3 Reasons to give through the CFC

Federal employees and military personnel (including retirees) can donate to the Foundation through the Combined Federal Campaign (CFC).

Why give through the CFC? Here are 3 great reasons:

1. Give through Payroll Deduction. Designate recurring gifts from each paycheck for a greater impact over time.

2. Unrestricted Funds for the Foundation. Your gifts will support our mission wherever they are needed most.

3. Give for Collective Impact. Changemakers like the federal community can help countless people with scleroderma when they give through the CFC.

To give to Foundation through the CFC, simply visit the CFC’s online pledge portal and choose #10089.


Heartland Sclero-What

Heartland Chapter 10th Annual Sclero-What? Education Day

ZOOM: October 15, 2022; 9 a.m. Eastern

Are you interested in learning about treating and managing scleroderma? The Heartland Chapter will host their 10th Annual Sclero-What? Education Day on October 15, 2022, which will cover topics such as  "New treatments for patients with SSc," "Gentle yoga and yogic breathing for symptom management in scleroderma," and "A Naturopathic Approach." There will also be over $800 in giveaways between speakers.

SIGN UP


Rochester Roundtable # 2 Oct 1st 2022

Tri-State Chapter Presents Albany & Rochester Educational Roundtable

ZOOM: October 1, 2022; 1 p.m. Eastern

The Tri-State Chapter will host their Albany & Rochester Educational Roundtable on October 1, 2022. If you are interested in learning how to advocate for your own health, sign up today! All are welcome to join.

SIGN UP


MN Education Event

National Scleroderma Foundation Minnesota Chapter Fall Mind Body Conference

ZOOM: October 15, 2022; 9 a.m. Eastern

The mind body connection can play an important role in autoimmune health. If you are interested in learning more about the mind body connection, sign up for the Mind Body Virtual Conference on October 15. The conference will cover topics such as "The Happiness Practice," "Research and Reasons for Mindfulness," and "Mind-Gut Connection." To learn more and sign up, visit the link!

SIGN UP


National Cancer Institute Study Logo

Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases

If you are an individual living with scleroderma and cancer, you might be eligible to take part in a new study focused on immunotherapy that is sponsored by the National Cancer Institute. This National Cancer Institute clinical trial is testing an immunotherapy drug (an anti-PD1 inhibitor, called nivolumab or Opdivo) in patients who have both cancer and an autoimmune disease, such as scleroderma. 

The trial’s scientific evidence could help develop new treatments for patients with scleroderma and help doctors better manage and prevent side effects from promising new treatments that are given to patients with autoimmune conditions who are otherwise good candidates for immune-based treatments for their cancer. The trials will take place in centers across the country, which can be seen in the link below. For participants at the trial locations in major cancer centers throughout the United States and at Princess Margaret in Toronto, Canada, the study drug will come at no cost, and treatment should be covered by insurance. Visit this link to learn more about the trial.

READ


University of New Mexico

Fathers with Scleroderma Needed for Survey Research Study on Parenting

Researchers from the University of New Mexico are seeking participants for a study exploring the impact of symptoms, such as pain and fatigue, on parenting in fathers who have systemic sclerosis (scleroderma). Fathers with scleroderma who have children 18 years and younger living with them may be eligible to participate in the survey study. This study was approved by the UNM Human Research Review Committee (HRRC 21-209). For more information about the study and the eligibility requirements, please contact Janet Poole PhD, OTR/L, at jpoole@salud.unm.edu or (505) 272-8276.

 Advertisement
September Horizon Ad
 
Splash Clinical Ad Fall Image
 
 
QUICK LINKS
Advocacy
Contact Us
Become a Member
What is Scleroderma
Calendar of Events
Online Chat
Make a Gift
Home
 
SOCIAL MEDIA
Facebook Twitter Instagram YouTube linkedin-icon
 
SPONSORS
 

Gold 
Janssen

 

Silver 

Boehringer Ingelheim

Horizon Therapeutics logo - 300px

 

 

Disclaimer: The National Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2024 All rights reserved.